Efficacy Of Sodium Glucose Transporter Inhibitor (SGLT2I) In Adult Patients With Congenital Heart Disease

NCT06260059 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Adult Congenital Heart Disease
Heart Failure

Interventions

DRUG: Empagliflozin 10 MG
DRUG: Placebo

Sponsor

Anita Saraf

Collaborators

[object Object]